Inazu M, Tujitani M
Pharmaceutical Research Laboratories, POLA R & D Laboratories, POLA Corporation, Yokohama, Japan.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):178-83. doi: 10.1007/BF00164796.
We have investigated relations between hypotensive responses to LP-805, a newly synthesized vasodilator, and the production of nitric oxide (NO), in anesthetized rats. LP-805 (0.1-0.5 mg/kg, i.v.) or acetylcholine (ACh) (0.3-3.0 micrograms/kg, i.v.) caused a dose-dependent transient decrease in diastolic blood pressure. The decrease induced by 0.3 mg/kg LP-805 (i.v.) was partially inhibited by pretreatment with NG-nitro-L-arginine (L-NNA), a specific inhibitor of endothelial NO synthase, but the responses to lower or higher doses of LP-805 (0.1 or 0.5 mg/kg, i.v.) were not affected. The dose-dependent decrease in diastolic blood pressure, caused by LP-805, was not affected by pretreatment with L- or D-arginine. The dose-dependent decrease in diastolic blood pressure caused by ACh was not affected by pretreatment with L-NNA or with L- or D-arginine. The hypotensive response to 20-min infusions of LP-805 (100 micrograms/kg per min) was significantly inhibited by pretreatment with L-NNA (10 mg/kg, i.v.). The half-recovery times (T 1/2) of LP-805 or ACh-induced depressor responses were shortened by pretreatment with L-NNA. They were prolonged by L-arginine, but not by D-arginine. This shortening, by L-NNA, of the half-recovery time after LP-805 or ACh was reversed by L-arginine, but not by D-arginine. The T 1/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin (1 mg/kg, i.v.). In the presence of L-NNA (10 mg/kg, i.v.), the T 1/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了新合成的血管舒张剂LP - 805的降压反应与麻醉大鼠体内一氧化氮(NO)生成之间的关系。LP - 805(0.1 - 0.5毫克/千克,静脉注射)或乙酰胆碱(ACh)(0.3 - 3.0微克/千克,静脉注射)可引起舒张压呈剂量依赖性的短暂下降。0.3毫克/千克LP - 805(静脉注射)引起的下降部分被内皮型一氧化氮合酶的特异性抑制剂NG - 硝基 - L - 精氨酸(L - NNA)预处理所抑制,但对较低或较高剂量的LP - 805(0.1或0.5毫克/千克,静脉注射)的反应未受影响。LP - 805引起的舒张压剂量依赖性下降不受L - 或D - 精氨酸预处理的影响。ACh引起的舒张压剂量依赖性下降不受L - NNA或L - 或D - 精氨酸预处理的影响。L - NNA(10毫克/千克,静脉注射)预处理可显著抑制对20分钟输注LP - 805(100微克/千克每分钟)的降压反应。L - NNA预处理可缩短LP - 805或ACh诱导的降压反应的半衰期(T 1/2)。L - 精氨酸可延长其半衰期,但D - 精氨酸不能。L - NNA对LP - 805或ACh后半衰期的缩短可被L - 精氨酸逆转,但不能被D - 精氨酸逆转。吲哚美辛(1毫克/千克,静脉注射)预处理不影响LP - 805诱导的降压反应的T 1/2。在存在L - NNA(10毫克/千克,静脉注射)的情况下,吲哚美辛预处理不影响LP - 805诱导的降压反应的T 1/2。(摘要截于250字)